Hematopoietic and Lymphoid System Neoplasm Recruiting Phase 2 Trials for SARS-CoV-2 vaccine (DB16427)

Back to Hematopoietic and Lymphoid System Neoplasm
IndicationStatusPhase
DBCOND0132171 (Hematopoietic and Lymphoid System Neoplasm)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04977024SARS-CoV-2 Vaccine (COH04S1) Versus Emergency Use Authorization SARS-COV-2 Vaccine for the Treatment of COVID-19 in Patients With Blood CancerTreatment